NCT06860399View on ClinicalTrials.gov

Vardenafil Vs Sildenafil for the Treatment of Pulmonary Hypertension of the Newborn

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

May 1, 2023

Primary Completion Date

September 30, 2024

Study Completion Date

September 30, 2024

Conditions
PPHN
Interventions
DRUG

Vardenafil

Oral Vardenafil

DRUG

Sildenafil

Oral Sildenafil

Trial Locations (1)

011

Children's Hospital, Damascus

All Listed Sponsors
lead

Damascus University

OTHER

NCT06860399 - Vardenafil Vs Sildenafil for the Treatment of Pulmonary Hypertension of the Newborn | Biotech Hunter | Biotech Hunter